Hans Hasselbalch

48PUBLICATIONS
117CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsRegenerative medicine (incl. stem cells)Gene and molecular therapyHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (48)

|Jul 10, 2026
Response to " Are statins interferons best friend? Mechanistic insights".

|Apr 08, 2026
A paradigm shift in the treatment of patients with polycythemia vera. The initial early use of recombinant interferon-alpha.

Richard T Silver, Hans Carl Hasselbalch

|Feb 26, 2026
Prime time for the use of statins in MPNs: from comorbidity drugs to disease-modifying partners.

Hans Carl Hasselbalch

|Dec 23, 2025
Atrial Fibrillation in Philadelphia Chromosome-negative Myeloproliferative Neoplasms: Thromboinflammatory Crosstalk with a Focus on the NLRP3 Inflammasome.

Olga Demska, Marta Szandruk-Bender, Niels Eske Bruun

|Sep 18, 2025
Statins enhance the efficacy of pegylated interferon-alfa2 in Philadelphia-negative chronic myeloproliferative neoplasms.

Isabella Diana Davidsen, Morten Kranker Larsen, Lea Löffler

|Aug 26, 2025
Reconsidering 'primary myelofibrosis with increased haemoglobin' within the myeloproliferative neoplasms biological continuum.

Hans Carl Hasselbalch

Pageof 8

Frequent Collaborators

29 joint publications

Vibe Skov

20 joint publications

Lasse Kjaer

15 joint publications

Morten Kranker Larsen

14 joint publications

Christina Ellervik